349692 <common-name>1-[3-[2,5-dioxo-3-(4-propan-2-yloxyphenyl)pyrrolidin-1-yl]propyl]-3-(4-propan-2-yloxyphenyl)pyrrolidine-2,5-dione</common-name> <description>1-[3-[2,5-dioxo-3-(4-propan-2-yloxyphenyl)pyrrolidin-1-yl]propyl]-3-(4-propan-2-yloxyphenyl)pyrrolidine-2,5-dione is a chemical compound with the formula C29H34N2O6. With an average molecular weight of 506.60 g/mol, 1-[3-[2,5-dioxo-3-(4-propan-2-yloxyphenyl)pyrrolidin-1-yl]propyl]-3-(4-propan-2-yloxyphenyl)pyrrolidine-2,5-dione is a heavy molecule.</description> <cas>115906-25-7</cas> <pubchem-id>3087706</pubchem-id> <chemical-formula>C29H34N2O6</chemical-formula> <weight>506.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T14:20:53Z</created-at> <updated-at type="dateTime">2026-08-31T14:20:53Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(C)OC1=CC=C(C=C1)C2CC(=O)N(C2=O)CCCN3C(=O)CC(C3=O)C4=CC=C(C=C4)OC(C)C</moldb-smiles> <moldb-formula>C29H34N2O6</moldb-formula> <moldb-inchi>InChI=1S/C29H34N2O6/c1-18(2)36-22-10-6-20(7-11-22)24-16-26(32)30(28(24)34)14-5-15-31-27(33)17-25(29(31)35)21-8-12-23(13-9-21)37-19(3)4/h6-13,18-19,24-25H,5,14-17H2,1-4H3</moldb-inchi> <moldb-inchikey>ZSTCYZPWOUFVIX-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">506.2416868</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>3.4</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM345585</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>1-[3-[2,5-dioxo-3-(4-propan-2-yloxyphenyl)pyrrolidin-1-yl]propyl]-3-(4-propan-2-yloxyphenyl)pyrrolidine-2,5-dione</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Pyrrolidines</klass> <subklass>Phenylpyrrolidines</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300015</sync-id> <structure-inchikey>ZSTCYZPWOUFVIX-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>44000000000000020000800000000000000000000000000000008000010000000000001000000020200000000000000000000000000000000000000800000000000000000010000000080000010000000022008000000100000200000000000000000002080000000000000000000000000000020100000000800000000000100000000040000000000000000000004000000000000000000000000000000001000000000000000000000000080000000000000000000002400000000040000000000000000000000000000000000000000000000004000000000200000000000010000000000000000040000000010000000000000000200000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKAAAAIABBgBgAAAAAQMGAGAAAAAD AQYAYAAAAAEDCAAoAAAAAwIGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZA KAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBgBgAAAAAwEGAGAAAAACAgYAKAAA AAMECAAoAAAAAwIHACgAAAADAwYAKAAAAAMECAAoAAAAAwIGAGAAAAACAgYA YAAAAAICBgBgAAAAAgIHACgAAAADAwYAKAAAAAMECAAoAAAAAwIGAGAAAAAC AgYAYAAAAAMBBgAoAAAAAwQIACgAAAADAgZAKAAAAAMEBkBoAAAAAwMBBkBo AAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEIACgAAAADAgYAYAAA AAMBBgBgAAAAAQMGAGAAAAABAwsAAQABAgABAwADBCAEBWgMBQZoDAYHaAwH CGgMCAloDAcKAAoLAAsMAAwNKAIMDiAODyAPECgCDhEAERIAEhMAExQAFBUg FRYoAhUXABcYABgZABkaKAIYGwAbHGgMHB1oDB0eaAweH2gMHyBoDB4hICEi ACIjACIkAAkEaAwPCgAZFCAgG2gMQgQAAAAGBAkIBwYFBQsKDw4MBRUUGRgX BhwdHh8gGxcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:47:45Z</structure-indexed-at> </compound>